==== Front PeerJ PeerJ peerj PeerJ 2167-8359 PeerJ Inc. San Diego, USA 15535 10.7717/peerj.15535 Biochemistry Cell Biology Molecular Biology Advances on the anti-tumor mechanisms of the carotenoid Crocin Bao Xingxun 1 Hu Jinhua 2 Zhao Yan 3 Jia Ruixue 1 Zhang Hairong sdzhhr7211@163.com 4 Xia Lei pathology001@sina.com 1 1 Shandong University of Traditional Chinese Medicine, Jinan, China 2 Shandong Provincial Hospital, Jinan, China 3 The Third Hospital of Jinan, Jinan, China 4 Shandong Provincial Third Hospital, Jinan, China Sobeh Mansour 29 6 2023 2023 11 e155352 12 2022 19 5 2023 ©2023 Bao et al. 2023 Bao et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. Saffron is located in the upper part of the crocus stigma of iridaceae, which has a long history of medicinal use. Crocin (molecular formula C44H64O24) is a natural floral glycoside ester compound extracted from saffron, which is a type carotenoid. Modern pharmacological studies have shown that crocin has multiple therapeutic effects including anti-inflammatory, anti-oxidant, anti-hyperlipidemic and anti-stone effects. In recent years, crocin has been widely noticed due to its considerable anti-tumor effects manifested by the induction of tumor cell apoptosis, inhibition of tumor cell proliferation, inhibition of tumor cell invasion and metastasis, enhancement of chemotherapy sensitivity and improvement of immune status. The anti-tumor effects have been shown in various malignant tumors such as gastric cancer, liver cancer, cervical cancer, breast cancer and colorectal cancer. In this review, we compiled recent studies on the anti-tumor effects of crocin and summarized its anti-tumor mechanism for developing ideas of treating malignancies and exploring anti-tumor drugs. Crocin Tumor Cancer Nanoliposome Mechanism The authors received no funding for this work. ==== Body pmcIntroduction Malignant tumours are a multifactor and multistep disease, the incidence of which has increased in recent years (Sung et al., 2021), but the pathogenesis has not been fully elucidated, so there is no effective aetiological treatment. Cancer is the second most deadly disease in the world (Fitzmaurice et al., 2017). Current cancer treatments include surgical intervention, radiation and chemotherapy drugs, which often kill healthy cells and cause a host of adverse reactions in patients. Chinese medicine plays a non-negligible role in tumor prevention and treatment with its characteristics, and it is gradually becoming an important strategy for tumor prevention and treatment because of its remarkable efficacy in improving clinical symptoms, as well as quality of life and prognosis of tumor patients. Saffron, is native to Iran, Persia and the Mediterranean region, and was introduced to China during the Ming Dynasty (Li, 2020). Saffron is listed in the Compendium of Materia Medica as one of the best medicines, with the effect of promoting blood circulation removing blood stasis, and relieving stagnation. Crocin is the main active ingredient in saffron, which is a water-soluble carotenoid (Hashemzaei et al., 2020; Liu et al., 2021), and is widely used in medicine, food and other fields because of its unique physicochemical property. Crocin can be detected in relatively few plants, mainly including saffron in iridaceae, gardenia in rubiaceae and other plants (Guo et al., 2021). Besides, there are significant differences in the content of crocin between different plants and among different parts of the same plant. For instance, crocin is mainly found in the stigma of saffron; while it is mainly detected in the pulp of gardenia, with less content in the peel and seed of this plant (He et al., 2010). Modern pharmacological studies have shown that crocin has various pharmacological activities, including anti-oxidant (Amin et al., 2014; Finley & Gao, 2017), anti-aging (Mohammadi et al., 2018), anti-inflammatory (Li et al., 2018; Liu et al., 2018; Yarijani et al., 2017), anti-liver fibrosis (Algandaby, 2018), anti-hyperlipidemia (Sheng et al., 2006), anti-epilepsy (Zhong et al., 2022), anti-anxiety and depression (Salek et al., 2021; Xiao et al., 2020), anti-cancer (Hoshyar & Mollaei, 2017; Jiang et al., 2018; Rahaiee et al., 2017), anti-stone (Ghaeni et al., 2014) and neuro-protective (Mozaffari et al., 2019) effects. Therefore, crocin has become a hot research topic in recent years with its significant effectiveness, low toxicity and high safety. As the deep pharmacological study of crocin, it has shown significant anti-tumor biological activity and is expected to become a potential drug for the treatment of malignant tumors. Here, we review the progress of crocin’s anti-tumor mechanism in order to provide new insights for solving the problems of traditional anti-tumor drugs that have poor efficacy, high toxic and side effects and drug resistance. The chemical structure of crocin is shown below (Fig. 1). Induction of apoptosis in tumor cells Apoptosis is a programmed cell death and its complexity has been the focus of numerous studies (Xu, Lai & Hua, 2019). The disruption of apoptotic mechanism is an important hallmark of cancer (Pistritto et al., 2016), and the induction of apoptosis is one of the important strategies for clinical cancer therapy. The apoptotic process can be mediated by a variety of signaling pathways. Tumor suppressor gene P53 P53 is a key tumor suppressor that plays a critical role in normal and cancer immunity (Agupitan et al., 2020). Loss of P53 function is a prerequisite for cancer development (Zhang et al., 2020a). p53 is highly correlated with tumors in the human body. The main biological function of p53 is to maintain the stability of cell genome, negatively regulate cell growth, and induce apoptosis. As revealed in a previous study (Jahromi et al., 2021), the growth of CO 88BV59-1 cells treated with crocin is significantly inhibited, and the expression of p53 is up-regulated. These findings indicate that crocin can promote apoptosis of CO 88BV59-1 cells in lymphoma in a time- and concentration-dependent manner by inducing the P53-dependent intrinsic pathway. 10.7717/peerj.15535/fig-1 Figure 1 Schematic diagram of the chemical structure of crocin. Mollaei et al. (2017) found that crocin downregulated B cell lymphoma-2 (Bcl-2) and miR-365 and up-regulated Bcl-2-associated X (Bax) and P53 in all time periods in human cervical cancer sensitive (OV2008) and resistant (C13) cell lines. The OV2008 cell line was more sensitive to crocin, which exhibited more significant change of gene expression than the C13 cell line. This study demonstrated the anti-proliferative and pro-apoptotic activity of crocin on sensitive and resistant cervical cancer cell lines, supporting that crocin could serve as an adjuvant drug to reduce chemotherapy resistance and improve therapeutic efficiency in cervical cancer treatment. In addition, MYCN gene as a transcriptional co-regulator of P53 has oncogenic effects (Agarwal et al., 2018). MYCN and p53 play opposite roles in normal development and cancer progression, but they are correlated with each other. Deng et al. (2019) observed significantly reduced expression and stability of MYCN as well as inhibited tumor cell proliferation and induced apoptosis in retinal glioma WERI-RB-1 cells after crocin treatment. The B lymphocytoma-2 (Bcl-2) family BCL-2 is an important member of the BCL-2 family with anti-apoptosis effect, and its overexpression reduces apoptosis and exerts oncogenic effects. As a cell death regulator, Bax is an indispensable gateway to mitochondrial dysfunction, and it is also a major pro-apoptosis protein in the Bcl-2 family that control the apoptosis of normal cells and cancer cells (Liu et al., 2016). Bax, Bcl-2 and their ratios are considered prognostic markers of various cancers (Kulsoom et al., 2018). Evidence (Bakshi et al., 2020) has shown that crocin reduced the cell viability of pancreatic cancer BXPC3 and Capan-2 by downregulating Bcl-2 and thus activating caspases. It also modulates the expression levels of proteins including P53, P21, P27, cyclin-dependent kinase (CDK)2, c-MYC, Cytochrome C (Cyt-c)and P38 involved in cell cycle signaling. Hoshyar, Bathaie & Sadeghizadeh (2013) found that crocin has a dose- and time-dependent cytotoxic effect on gastric adenocarcinoma AGS cell lines. The increased number of G1-phase cells and activated caspases with an increased Bax/Bcl-2 ratio were observed in AGS cells after crocin treatment, which confirmed the anti-cancer effect of crocin. The apoptotic cells were significantly increased in crocin-treated AGS cells, while the above indicators (G1 phase cells, Bax/Bcl-2 ratio, and apoptotic cells) were normal in crocin-treated fibroblasts (HFSF-PI3), which indicated that crocin had no significant toxic effect on normal cells. Liu (2016) detected the evident inhibition of crocin to the proliferation of HPAC cells with a dose-dependent manner measured by MTT method. ELISA results showed that the expression of caspase-3 protein in the crocin group was significantly higher than that in the blank control group, which suggested that crocin could inhibit the proliferation of human pancreatic cancer HPAC cells and induce apoptosis of HPAC cells. Janus kinase/signal transducer and activator of transcription 3 (JAK/STAT3) JAK/STAT3 signaling pathway drives tumor cell proliferation, survival, invasion, and metastasis while suppresses anti-tumor immune responses (Johnson, O’Keefe & Grandis, 2018). Therefore, JAK/STAT3 pathway inhibitors can deter tumor cell growth and stimulate anti-tumor immunity. Crocin inhibits extracellular signal-regulated kinase (ERK) and JAK/STAT signaling pathways in thyroid follicular carcinoma FTC-133, thereby inhibiting tumor cell proliferation and promoting apoptosis (Zhang et al., 2021). Wang, Ke & Shu (2020) observed that crocin reduced the phosphorylation level of STAT3 and inhibited the proliferation of colon cancer cells (HCT116) in a dose-dependent manner. In addition, it was found that crocin significantly inhibited the growth of colorectal cancer cells without toxic effects on normal cells (Aung et al., 2007). Kim & Park (2018) found that crocin inhibited the proliferation of hepatocellular carcinoma cells (Hep3B and HepG2) and promoted apoptosis through targeting interleukin(IL)-6/STAT3 pathway by inhibiting JAK1/2 and Src kinases. In addition, crocin induced the expression of Src homology region 2 domain-containing phosphatase 1(SHP-1), leading to STAT3 dephosphorylation. While knockdown of SHP-1 expression using siRNA attenuated the effect of crocin, suggesting that SHP-1 played an important role in STAT3 signaling. Moreover, crocin downregulated the expression of cyclin D1 (proliferation), chemokine CXC motif receptor (CXCR) 4 (invasion), and vascular endothelial growth factor (VEGF)(angiogenesis) mediated by STAT3, but increased the expression of Bax (pro-apoptotic protein), indicating that crocin was associated with induction of apoptosis and inhibition of cell proliferation. This study demonstrated that crocin has anti-tumor activity through inhibiting IL-6/STAT3 signaling pathway. Reactive oxygen species (ROS) ROS is a group of short-lived, highly reactive, oxygen-containing molecules that induce DNA damage and cause genotoxic stress, which plays a dual role in tumor. ROS can activate pro-tumorigenic signals, enhance tumor cell survival and proliferation, induce DNA damage and genetic instability, and initiates oxidative stress-induced tumor cell death (Moloney & Cotter, 2018; Srinivas et al., 2019). miR-34a-5p is upregulated and exerts pro-tumorigenic effects in papillary thyroid cancer (PTC), and its downregulation by crocin inhibits tumor cell growth (Tang et al., 2022). Protein tyrosine phosphatase nonreceptor (PTPN)4 is the most significantly downregulated target gene in thyroid cancer tissues, and PTPN4 can be upregulated through downregulating miR-34a-5p expression by crocin in PTC cells. Tang et al. (2022) demonstrated that crocin promoted thyroid cancer TPC-1 and IHH-4 apoptosis and increased caspase-3 activity and lactate dehydrogenase (LDH)release, which was reversed by overexpressing NAC and miR-34a, suggesting that crocin promoted ROS-mediated apoptosis in PTC cells by regulating the miR-34a-5p/PTPN4 axis. Nasimian et al. (2020) found that crocin induced ROS production, increased forkhead box O3 (FOXO3a) expression and facilitated nuclear translocation in breast cancer cell lines (MCF-7 and MDA-MB-231), which in turn increased the expression of FOXO3a target genes (Bim and phosphatase and tensin (PTEN)) and activation of caspase-3. NAC blocked the protein kinase B (AKT)/FOXO3a/Bim signaling pathway. Consequently, it could be concluded that crocin induces apoptosis in breast cancer cell lines (MCF-7 and MDA-MB-231), where ROS-activated FOXO3a cascade plays a key role in this process. Schematic diagram of crocin inducing apoptosis of tumor cells (Fig. 2). Inhibition of tumor cell proliferation Cell proliferation is an important component of cell growth and differentiation (Díaz-Coránguez, Liu & Antonetti, 2019), and the abnormal cell proliferation is a typical feature of cancer (Jarrett et al., 2018), accompany with loss of differentiation and maturation for different levels. Therefore, inhibition of tumor cell proliferation is an important part of the anti-tumor treatment. At present, there are two ways to control tumor cell proliferation. One is to kill and inhibit the growth of tumor cells by improving the immunity of patients themselves, and the other is to stagnate tumor cell mitosis and control tumor growth through drug administration. Blocking cell cycle Cell division is strictly regulated by multiple evolutionarily conserved cell cycle regulatory mechanisms (Matthews, Bertoli & De Bruin, 2022). Targeting cell cycle components may be an effective anti-cancer strategy. In a mouse model of breast cancer, the expression of cyclin D1 and p21 was elevated, while crocin could minish the tumor size of mouse model by inhibiting the expression of D1 and p21 (Ashrafi et al., 2015). In vitro experiments (Chen et al., 2019) also showed that crocin could induce cell cycle arrest in the G2/M phase of human breast cancer cells (MDA-MB-231) in a dose-dependent manner. Sun et al. (2013) showed that crocin could induce apoptosis and cell cycle arrest in the G0/G1 phase leukemia cells (HL-60) in a dose-dependent manner thereby inhibiting the proliferation of leukemia cells. Amin et al. (2016) illustrated that crocin had an anti-proliferative effect on hepatocellular carcinoma cells (HepG2) by blocking S and G2/M phases of cell cycle, inducing apoptosis and down-regulating the inflammatory response. In vivo experiments showed that crocin significantly inhibited the inflammatory response induced by hepatocellular carcinoma cells in rats and suggested crocin as a candidate chemopreventive agent for hepatocellular carcinoma. Xia (2015) presented that crocin markedly inhibited the growth of ovarian carcinoma cells (HO-8910) and blocked them in the G0/G1 phase. In addition, crocin also promoted apoptosis in HO-8910 cells possibly through activating the expression of p53 and Fas/APO-1, which in turn activated caspase-3 apoptotic pathway. 10.7717/peerj.15535/fig-2 Figure 2 Schematic diagram of crocin inducing apoptosis of tumor cells. Tubulin Tubulin is one of the most important intracellular proteins, involved in almost all cell biological processes. However, tubulin was differentially expressed in normal and tumor cells, which provides ideas for the development of tumor chemotherapeutic drugs (Binarová & Tuszynski, 2019). Tubulin is also the main target of crocin in anti-tumor activity (Wang et al., 2020). Studies have shown (Zarei Jaliani et al., 2013) that crocin entering in cells can regulate cellular proteins and their functions, and can affect a variety of cellular processes by interacting with tubulin or microtubules. Hire et al. (2017) found that crocin inhibited mitosis and induced multipolar spindle formation by targeting microtubules, and thus suppressed the proliferation of breast cancer cells (HCC70 and HCC1806) and cervical cancer cells (Hela cells). Liao et al. (2022) discovered that crocin could evidently weaken viability, migration and invasion, and induce apoptosis of gastric cancer cells (MGC-803) by decreasing tubulin expression. Crocin also inhibited the proliferation of mouse gastric cancer cells (AGS) and tumor growth by decreasing tropomyosin (TPM) 4 expression, while TPM4 overexpression could resist the anti-tumor effect of crocin (Luo et al., 2021). Nuclear factor kappa-B (NF- κB) pathway NF- κB has been early considered as a potential target for cancer therapy, and dysregulation of NF- κB activity leads to inflammatory diseases and cancer (Yu et al., 2020). Studies have shown that crocin inhibits the activation of NF- κB pathway (Hussain et al., 2021; Shi et al., 2018; Teng et al., 2021; Zhang et al., 2022b). Xu et al. (2022) showed that crocin inhibited NF- κB activation and the expression of tumor necrosis factor- α (TNF- α) and IL-1 β, and thereby decreasing the viability and proliferation of breast cancer DA-MB-231 and MDA-MB-468 cells. Nuclear transcription factor E2 related factor 2 (Nrf2) is a major transcription factor for redox regulation and an important target of crocin. Crocin could reduce the probability of colon cancer by inhibiting NF- κB expression and promoting Nrf2 expression in adenocarcinoma of colon cells (Kawabata et al., 2012). Schematic diagram of crocin inhibiting tumor cell proliferation (Fig. 3). 10.7717/peerj.15535/fig-3 Figure 3 Schematic diagram of crocin inhibiting tumor cell proliferation. Inhibition of tumor cell metastasis and invasion Invasion and metastasis are critical characteristics of malignant tumors and play an important role in the development of cancer (Guan et al., 2020; Zeng et al., 2019). Therefore, inhibition of tumor cell invasion and metastasis plays a crucial role in cancer treatment. Vascular endothelial growth factor (VEGF) Angiogenesis is essential for cancer development and growth, and VEGF is a key signal for cancer angiogenesis (Carmeliet, 2005). Evidence has shown that downregulating VEGF expression leads to tumor immunosuppression (Zhang & Brekken, 2022), and this finding is of positive value for tumor treatment. Previous studies demonstrated that crocin could downregulate VEGF expression and reduce tumor volume in mice, thus improving their survival (Farahi et al., 2021). In an experimental study by Bakshi et al. (2022), it was mentioned that crocin inhibited TNF- α, NF- κB and VEGF pathways in colon cancer cells (HT-29 and Caco-2) in a dose-dependent manner, thereby inhibiting migration, invasion and angiogenesis of colon cancer cells. Moreover, it was found that crocin was involved in the regulation of molecules in the angiogenic pathway such as downregulating cluster of differentiation (CD)34 expression to exert anti-angiogenic effects (Chen et al., 2019). In addition, crocin could inhibit tumor cell proliferation and reduce microvessel density in vivo, and inhibit vascular endothelial cell proliferation, migration and tubule formation in vitro, revealing the main mechanism of crocin in anti-angiogenesis (Chen et al., 2016). Epithelial-mesenchymal transition (EMT) EMT endows the ability of cells to invasion and metastasis, which plays a key role in cell development, as well as tissue healing, organ fibrosis and carcinogenesis. In cancer progression, EMT leads to fundamental changes in cell morphology and motility that promote cell invasion (Brabletz et al., 2021). matrix metalloproteinase (MMP) 9 is a matrix protein associated with extracellular matrix (ECM) remodeling that promotes tumor progression and regulates the activity of cell adhesion molecules and cytokines (Joseph et al., 2020). Bakshi et al. (2017b) found that crocin inhibited the expression of MMP-2, MMP-9, ERK-2, K-ras and VEGF, and attenuated the ability of melanoma cells (B16F-10) to invade, migrate, and adhere by upregulating the expression of E-cadherin. Human gastric mucosal epithelial cells (GES-1) have malignant cell characteristics such as proliferation, apoptosis, and metastatic ability. Wu & Hui (2020) found that crocin could arrest G0/G1 phase cycle, inhibit cell proliferation and promote apoptosis in GES-1 cells. In addition, crocin negatively regulated the invasive ability and EMT process of 1-methyl-3-nitroso-1-nitroguanidine (MNNG)-treated GES-1 cells, whose mechanism is possibly by inhibiting MNNG-induced malignant transformation through Nrf2/Hippo signaling pathway. Therefore, crocin may be a candidate for clinical treatment of gastric cancer. The expression levels of krüppel like factor 5 (KLF5) and hypoxia inducible factor-1 α(HIF-1 α)were elevated in gastric cancer tissues and cells, and the expression of KLF5 was positively correlated with the level of HIF-1 α in gastric cancer tissues. Zhou et al. (2019) demonstrated that crocin could inhibit EMT, migration and invasion of gastric cancer cells (AGS and HGC-27) by targeting miR-320/KLF5/HIF-1 α signaling pathway specifically via down-regulating the expression levels of KLF5 and HIF-1 α and up-regulating miR-320 expression. Wnt/ β-catenin signaling pathway β-catenin is particularly important for morphogenesis and cellular organization during embryogenesis (Schunk et al., 2021), and aberrant activation of β-catenin signal is strongly associated with increased mortality of cancer (Yu et al., 2021). Evidence showed that crocin inhibited colon cancer cell growth and invasive behavior by regulating Wnt pathway and E-calmodulin, and could significantly reduce tumor size and alleviate the symptoms alone or in combination with 5-fluorouracil (Amerizadeh et al., 2018). In breast cancer mice (BALB/c) model induced by injecting breast cancer cells (4T1), Arzi et al. (2018) found that the mice treated with crocin had increased weight, improved survival and smaller tumors. Histological examination did not reveal metastatic deposits in the liver and lungs. Compared to the untreated group, the expression of target genes within Wnt/ β-catenin signaling was down-regulated in tumor and lung tissues in the treated group. Moreover, crocin had no significant toxic side effects, thus crocin could be considered as a promising complementary drug against metastasis. The inhibitory effect of crocin on tumor cell invasion and migration (Fig. 4). 10.7717/peerj.15535/fig-4 Figure 4 Inhibitory effect of crocin on invasion and migration of tumor cells. Nano-liposome drug delivery enhances efficiency and reduces toxicity The pharmacological use of carotenoid compounds is limited by their lower bioavailability and solubility. Nano-liposomal drug delivery has the advantages of good biocompatibility, broad adaptability and bioavailability. Phospholipids are cell membrane components, which are non-toxic and do not cause immune response when injected into the body. Importantly, phospholipids can protect drugs from dilution by body fluids and decomposition by enzymes in the body, which are popularly used in drug delivery (Palassi et al., 2021). Khan et al. (2020) prepared a combination of crocin and adriamycin as nanoparticles and found that the nanoparticles were capable to produce cytotoxic effects on breast cancer cells by reducing ROS and altering mitochondrial potential, leading to apoptosis and G2/M phase cell cycle arrest. Mousavi et al. (2011) discovered that liposome encapsulation of crocin performed the enhanced cytotoxic effects on HeLa and MCF-7 cells. Rastgoo et al. (2013) developed crocin nanoliposomes for the treatment of malignant tumors and demonstrated their antitumor activity in C26 colon cancer BALB/c mice. Functionalized nanoparticles are specifically designed for drug delivery to tumor cells and can potentially enhance the anti-cancer activity of the drug. The nano-sized magnetite particles can be easily absorbed by the organisms, and when injected into animals, they degrade over time reusable by body cells. El-Kharrag et al. (2017) observed the favorable outcome of crocin-coated magnetic nanoparticles (MNPs) in treating liver cancer, shown as the regression of precancerous lesions and significant increase of apoptotic cells after treatment. The mechanism of crocin-coated MNPs may be related to the downregulation of Bcl-2, VEGF, and cyclooxygenase-2 (COX-2)expression. Crocin nanoparticles were found to have significant cytotoxic effects on breast cancer cells, suggesting that nanoparticles as drug carriers could enhance the anti-cancer effects of crocin (Hoshyar et al., 2016). Combination of crocin and standard drugs to increase effectiveness and reduce toxicity Resistance of tumor cells to chemotherapeutic agents after a period of treatment is a serious problem. Commonly used chemotherapeutic drugs are prone to generate intolerance or tumor resistance, so there is an urgent need to develop new clinical drugs with increased efficacy and reduced toxicity. Multiple resistance-associated proteins 1 and 2 (MRP1 and MRP2) are important factors responsible for the failure of cancer chemotherapy. It was shown that crocin inhibited drug resistance by downregulating the expression of MRP transporter proteins in human ovarian cancer drug-resistant cell lines (Mahdizadeh et al., 2016). In the combination therapy of crocin and cisplatin in human gastric cancer cells (BGC-823), the cancer cell proliferation was suppressed and the apoptosis was promoted (Luo et al., 2017), which may result from the increased expression of p53 and Bax and decreased expression of Bcl-2 in BGC-823 cells. Based on the results of the above experiment, it could be speculated that crocin combined with cisplatin may be a promising drug for the treatment of gastric cancer. Li et al. (2021b) found that crocin combined with cisplatin could synergistically inhibit the proliferation and growth of human cervical cancer HeLa cells, and its mechanism may be related to the regulation of apoptosis-related protein expression for promoting apoptosis and blocking cell cycle. The elevated expression levels of Cleaved Caspase-3 and Bax proteins, and the increased ratio of Bax/Bcl-2 were displayed in the combination group (crocin and cisplatin) compared with the cisplatin group. In addition, the ratio of G0/G1 phase was significantly higher while the ratio of G2/M phase was significantly lower in the combination group than that in the cisplatin group. In a study on the effect of crocin combined with cisplatin on the proliferation and apoptosis of BGC-823 cells, it was found that compared with the blank group, the combination group exhibited higher inhibition rate of cell proliferation, significantly lower expression of p-ERK1/2 and Bcl-2 proteins, and significantly higher expression of Bax and cleaved-caspase3 proteins (Xu & Luo, 2019). This suggests that crocin combined with cisplatin blocked the proliferation and promoted the apoptosis of BGC-823 cells probably by the inhibition of ERK signaling pathway. Abdu et al. (2022) found that crocin or sorafenib or the combination of both successfully restored the normal liver structure in hepatocellular carcinoma rat model. The expression of key genes involved in carcinogenesis (TNF- α, p53, VEGF, and NF- κB) was highly activated in hepatocellular carcinoma and was significantly attenuated after treatment with crocin or sorafenib or the combination of both. The combination group (crocin and sorafenib) showed more favorable performance in improving histopathological and inflammatory response than monotherapy (crocin or sorafenib). The administration of crocin or sorafenib alone or their combination produced cytotoxicity and anti-cancer effects on HepG2 cells, and the combination of crocin and sorafenib had synergistic antitumor effects on HepG2 cells as well. The results showed that the combination of crocin and sorafenib regimen reduced hepatotoxicity, hindered the progression of hepatocellular carcinoma, and improved liver function. The researchers proved that crocin strikingly improved the sensitivity of head and neck cancer cells (HN-5) to the combination therapy of HER1 inhibitor and radiotherapy (Torres et al., 2011). Vazifedan et al. (2017) also found that crocin inhibited the proliferation of HN-5 cells by enhancing the sensitivity of cancer cells to radiation-induced toxicity and apoptosis. Yin & Xiong (2022) showed that in cisplatin-treated cancer cells, crocin significantly reduced the levels of serum creatinine and blood urea nitrogen as well as malondialdehyde, and increased the levels of glutathione, glutathione peroxidase, catalase and superoxide dismutase in lipid peroxidation process. Crocin also significantly inhibited the activation of p38 mitogen-activated protein kinase and expression. In conclusion, crocin prevented cisplatin-induced oxidative stress and hepatorenal toxicity by attenuating the cleavage of p38 mitogen-activated protein kinase and caspase-3. Immunomodulatory function Under normal circumstances, the organisms can timely recognize and remove mutated cancer cells in the body through immune surveillance. Immunosuppression is the key feature of tumor inflammatory microenvironment. Improving suppressive tumor microenvironment and reshaping tumor immunity is an effective way to improve clinical efficacy of cancer treatment (Tian et al., 2017). Immunotherapy is of great importance for improving survival in children with acute lymphoblastic leukemia (ALL). Zhang et al. (2018) found that crocin could significantly accelerate T cell proliferation and promote IL-2 and IL-4 secretion in a dose-dependent manner. In addition, crocin could increase the CD4/CD8 ratio of T cells and reduce DNA damage in T cells without damage to T cells. Khavari et al. (2015) investigated the in vitro cytotoxic and apoptotic effects of saffron aqueous extract in malignant (TC-1) and non-malignant (COS-7) cell lines. The study examined the inhibitory effect of E7-NT (gp96) DNA vaccine alone and its combination with saffron extract on tumor growth with a large size. Saffron extract exerted significant anti-tumor effects by inhibiting cell growth and stimulating programmed cell death. The cytotoxicity of saffron extract on TC-1 cells was greater than that on COS-7 cells, indicating its anti-tumor activity. An investigation showed that (Xu et al., 2012) crocin in combination with cytokines had a stronger effect to promote the proliferation of myeloid dendritic cells than crocin alone, and crocin performed a synergetic effect with cytokines to facilitate the maturation of myeloid dendritic cells. crocin-induced myeloid dendritic cells could promote the proliferation of T cells. Jiang et al. (2018) evaluated the effects of crocin on cervical cancer through examining the changes of body weight, serum enzymes, serum biochemistry, lipid peroxidation and DNA damage in male albino rats treated with crocin. The results revealed that crocin significantly reduced tumor weight, decreased the levels of alanine aminotransferase, aspartate aminotransferase, lactate dehydrogenase, alkaline phosphatase, blood urea nitrogen, creatinine, bilirubin, albumin and total protein, and increased the levels of glucose and cholesterol in rats. Hemoglobin, leukocytes, lymphocytes, neutrophils, and filler cell volume were altered after crocin treatment, as well as the occurrence of necrosis, fibrosis, mononuclear infiltration, angiogenesis, and DNA fragmentation, suggesting that crocin may be a potential anti-cancer agent for treating cervical cancer. Others Lipid metabolism pathway A metabolic change in the lipid metabolic pathway is one of the indicators in human cancers (Merino Salvador et al., 2017). Lipid metabolism involves a complex regulatory process. Changes in lipid metabolism can not only meet the energy demand of cancer cells, but also contribute to the activation of several important carcinogenic signaling pathways (Yi et al., 2018). Cholesterol metabolites can actively promote cancer progression and suppress immune responses (Huang, Song & Xu, 2020). Triglyceride can be regarded as a biomarker for the diagnosis or prognosis of colorectal cancer (Yarla, Madka & Rao, 2022), and its metabolic dysregulation is related to the occurrence and progression of cancers. It has been revealed that crocin can effectively reduce the levels of cholesterol (Mirzaee et al., 2019; Zhang et al., 2022a) and triglyceride (Luo et al., 2019; Rahmani et al., 2019; Song et al., 2022) in serum. Hashemi, Bathaie & Mohagheghi (2020) explored the influence of crocin on the lipid content in breast cancer. It was found that crocin can inhibit tumor progression by reducing cholesterol and triglyceride in the serum of tumor-bearing mice and MDA-MB-231 and MCF-7 cell lines in breast cancer. In summary, the lipid-lowering effect of crocin is of great significance for the prevention of cancer progression, metastasis, and invasion. Autophagy Autophagy is an intracellular degradation process (Li et al., 2017), and it is crucial for maintaining cellular homeostasis (Li et al., 2021a). Autophagy is closely related to malignant transformation, tumor progression, and treatment (Yamazaki et al., 2021). The dysregulation of miR-320a has been confirmed in various malignant tumors (Yang et al., 2014). In cutaneous squamous cell carcinoma (cSCC), the expression of miR-320a is significantly up-regulated, while that of ATG2B is significantly down-regulated. miR-320a can inhibit autophagy, while crocin can significantly inhibit the growth of cSCC cells and induce apoptosis through autophagy. Therefore, the inhibitory effect of crocin on cSCC may be obtained by targeting the ATG2B/miR-320a pathway (Bi et al., 2021). Crocin can significantly promote autophagy, accompanied by the activation of adenosine 5′-monophosphatate (AMP)-activated protein kinase (AMPK). Based on that, Zeng et al. (2016) maintained that the autophagy and apoptosis of cells induced by crocin correlated with AMPK, AKT, and mTOR. Zhang et al. (2020b) found that the proportion of LC3II/I, Beclin1, and ATG7 in SiHa cells in cervical cancer increased significantly after being treated with crocin. Hence, crocin may promote autophagy and apoptosis by reducing AMPK and mTOR signal transduction. LC3-II is expressed during autophagy, and its accumulation is an indicator of autophagy (Amelio, Melino & Knight, 2011; Klionsky, Cuervo & Seglen, 2007). Amin et al. (2015) found that the proliferation of HCT116 cells was inhibited after being treated with crocin in colorectal cancer. Further, the expression of LC3-II protein was significantly up-regulated in crocin-treated cells. These results suggested that the inhibition of crocin on HCT116 cells might be realized by promoting the expression of LC3-II and triggering autophagy. However, autophagy may play different roles at different stages of cancer development. As per another study (Feidantsis et al., 2018), crocin can enhance the heat shock response of myocardial cells and inhibit apoptosis by targeting autophagy. In short, autophagy plays a role in tumor inhibition and promotion. Therefore, it is necessary to further clarify the exact mechanism of autophagy in cancers. Chemoprevention Natural products have always been considered one of the most important resources of anticancer agents. Chemoprevention refers to the prevention or inhibition of canceration through the intervention of natural or synthetic products. According to the theory of traditional Chinese medicine (TCM), the occurrence of tumors is related to qi-stagnancy and blood stasis in the human body. Since saffron has an effect on activating blood circulation to dissipate blood stasis, this herbal medicine can be applied to the prevention and treatment of malignant tumors. As a carotenoid, crocin is an active component in saffron. According to modern medicine, carotenoids are common antioxidants and have anti-mutagenic and immunomodulatory functions (Brewczyński et al., 2021). It has also been demonstrated in an epidemiological study (Milani et al., 2017) that there is a correlation between carotenoid intake in diet and cancer risks. In addition, crocin can significantly inhibit the expression of JNK in the liver, and up-regulate the expression of apoptosis-inducing ligand, caspase-8 protein, and p53 gene (Elsherbiny et al., 2020). Therefore, it is considered that crocin can reduce the probability of liver cancer induced by experiments via regulating oxidation/apoptosis signals. Sajjadi & Bathaie (2017) found that crocin could exert protective effects on rats in the occurrence of breast cancer induced by N-Nitroso-N-methylurea (NMU). The incidence of breast cancer in rats was 77% after NMU injection, while that decreased to 45% after crocin treatment. The extract of saffron also inhibited the formation of papilloma induced by 7,12-dimethylbenz [a] anthracene and reduced the average number of papilloma in mice (Randhawa & Alghamdi, 2011). Moreover, Bakshi et al. (2017a) and Bakshi et al. (2017b) found in a mouse model of melanoma that crocin treatment can significantly reduce the tumor burden, lengthen the tumor dormancy, reduce the tumor growth rate, and prolong the average survival of mice. These results corroborate that crocin in saffron has obvious chemoprevention effects on tumors. saffron has been applied in the treatment of various diseases, including cancer, for a long time (Li, Lee & Wu, 2004). The findings of some experimental studies in vivo and in vitro mentioned above indicate that crocin, as a natural active ingredient, has fewer toxic and side effects, strong efficacy, and multiple targets in relevant treatment.A summary of the anti-tumor effects of crocin and its anti-tumor mechanism are shown below (Tables 1 and 2 and Fig. 5). 10.7717/peerj.15535/table-1 Table 1 Antitumor effect and signaling pathway of crocin in vitro. Work way Cell type Concentrations Signaling pathways Selective toxicity REF Apoptosis CO 88BV59-1 80 µM p53 Yse (B-lymphocyte) 28 OV2008 1.5mg/ml Bax/Bcl-2, p53 Not mentioned in the article 29 WERI-RB-1 20 µM MYCN Not mentioned in the article 31 BXPC3, Capan-2 10, 20, 40 µg/mL Bcl-2, caspase Not mentioned in the article 34 AGS 2.5 mg/mL Caspases, Bax/Bcl-2 Yes (HFSF-PI3) 35 HPAC 2.5, 5, 10mg/ml Caspases-3 Not mentioned in the article 36 FTC-133 15, 20 µM ERK, JAK/STAT Yes (PCCL3) 38 HCT116 135.6, 271.18 µM STAT3 Not mentioned in the article 39 HepG2 20 µM IL-6/STAT3 Not mentioned in the article 41 Hep3B 20 µM STAT3, Bax Not mentioned in the article 41 TPC-1 and IHH-4 40 µM caspase-3, LDH Not mentioned in the article 44 MCF-7, MDA-MB-231 2.7, 3 mM ROS, FOXO3a Not mentioned in the article 45 Proliferation MDA-MB-231 5.97 mg/mL CD34 No (HUVEC) 50 HL-60 5.0 mg/mL Not mentioned in the article 51 HepG2 1mM IL-8 Not mentioned in the article 52 HO-8910 1.0 mmol/L Not mentioned in the article 53 HCC70, HCC1806, HeLa 50 µM tubulin Yes (CCD1059sk) 57 MGC-803 100 ng/m L α-Tubulin Not mentioned in the article 58 AGS 2, 4, 6 mg/mL TPM4 Not mentioned in the article 59 DA-MB-231, MDA-MB-468 4 mg/mL NF- κB, TNF- α, IL-1 β Not mentioned in the article 65 GES-1 3, 10 µM Nrf2/Hippo Not mentioned in the article 77 Metastasis HT-29, Caco-2 10, 20, 40 µg/mL VEGF Yes (HCEC) 72 MDA-MB-231 5.97 mg/mL CD34 No (HUVEC) 50 GES-1 10 µM Nrf2/Hippo Not mentioned in the article 77 AGS, HGC-27 2, 3 µM miR-320/KLF5/HIF-1 α Yes (GES-1) 78 Nanoliposomes administration mode MDA-MB-231, MCF-7 1, 5, 25 µM ROS Yes (HBL-100, H9c2) 84 HeLa, MCF-7 1.2 mM LC3II/I, Beclin1 ATG7 Yes (L929) 85 HepG2 3 mg/ml Bcl-2, VEGF, COX-2 Not mentioned in the article 87 MCF-7 3 mg/ml Not mentioned in the article 88 Combination with cisplatin BGC-823 8, 16 mg/mL Bax/Bcl-2, p53 Not mentioned in the article 90 HeLa 400 µg/mL Cleaved Caspase-3, Bax/Bcl-2 Not mentioned in the article 91 BGC-823 8 mg/ml p-ERK1/2, Bcl-2, Bax, cleaved-caspase3 Not mentioned in the article 92 Combination with sorafenib HepG2 50-300 µM TNF- α, p53, VEGF NF- κB Not mentioned in the article 93 Enhanced radiation sensitivity HN-5 12.5-1000 µg/mL Not mentioned in the article 95 Metabolism of fat MDA-MB-231, MCF-7 2-5 mg/ml Chl/TG Not mentioned in the article 110 Autophagy A431, SCL-1 1, 2, 4 mM ATG2B/miR-320a Not mentioned in the article 115 SiHa 2, 4, 8, 16 mM AMPK mTOR Not mentioned in the article 117 HCT116 10mM LC3-II Not mentioned in the article 120 10.7717/peerj.15535/table-2 Table 2 Antitumor effect and signaling pathway of crocin in vivo. Work way Tissue type Dosage Signaling pathways Selective toxicity REF Proliferation Breast tumors 200 mg/kg/d CyclinD1, P21 Not mentioned in the article 49 Colonic adenocarcinomas 50, 100, 200 ppm NF- κB, Nrf2 Yes 66 Metastasis Melanoma 250, 500 µg/kg/d MMP-2, MMP-9, VEGF Not mentioned in the article 76 Breast cancer 200 mg/kg/d Wnt/ β-catenin Not mentioned in the article 82 Nanoliposomes administration mode Colon carcinoma 50, 100 mg/kg/d Not mentioned in the article 86 Combination with cisplatin Kunming mice 6.25, 12.5 mg/kg/d P38, p53, caspase-3 Not mentioned in the article 96 Autophagy Cardiac tissues 50 mg/kg/d AMPK, AKT, mTOR Not mentioned in the article 116 Safety and Tolerance Clinical Trials Safety and tolerance of drugs are major concerns in relevant clinical trials. In a clinical trial on the subjects with mild to moderate sleep disorders related to anxiety (Pachikian et al., 2021), the sleep quality in the treatment group (crocin was administered at 15.5 mg daily for 6 weeks) was improved, while that in the placebo group did not change significantly, and no serious adverse events were reported. In another trial on diabetic macular edema (Sepahi et al., 2018), crocin was administered as a supplement at 15mg daily for 3 consecutive months. It was observed that crocin (15mg) contributed to reducing inflammatory responses in patients with diabetic maculopathy. It is demonstrated that crocin can be used as an effective antioxidant and neuroprotective agent with favorable tolerance. Chemotherapy-induced peripheral neuropathy (CIPN) is one of the complications in patients treated with anticancer drugs. In an 8-week clinical trial (Bozorgi et al., 2021), crocin achieved excellent efficacy in relieving CIPN symptoms of cancer patients treated with chemotherapy drugs, mainly manifested in analgesic effects. This suggests that crocin can be used as a supplement to anti-tumor drugs. In a clinical study investigating the effect of saffron on plasma cholesterol ester transfer protein (CETP) levels in patients with metabolic syndrome, participants were randomly assigned to either a saffron group (30 mg/d) or a placebo group (Javandoost et al., 2017). The study lasted for eight weeks during which lipid metabolism markers and CETP levels were recorded. Results showed that, compared to the control group, the saffron group demonstrated improved CETP levels, triglyceride, and low-density lipoprotein cholesterol. This improvement trend strengthened with the extended treatment time. Participants were monitored for safety during the study period, with no serious adverse reactions or side effects identified. Therefore, this study suggests that saffron is relatively safe at doses used. 10.7717/peerj.15535/fig-5 Figure 5 Main anti-cancer molecular pathways mediated by crocin. Although this trial provided helpful information, it was limited to patients with metabolic syndrome; thus, further studies are necessary to explore its applicability to healthy individuals. Additionally, the study did not consider the effects of different doses and durations on treatment efficacy. Therefore, additional laboratory tests, animal experiments, and clinical trials are required to more accurately evaluate the effectiveness and side effects of saffron as a metabolic syndrome treatment. A randomized, double-blind, placebo-controlled trial was conducted to evaluate the effects of saffron on inflammation markers, lipid levels, insulin, and cardiac protection in women diagnosed with polycystic ovary syndrome (PCOS) (Rahimi, Shams & Aslani, 2022). In this study, 60 participants with PCOS were randomly assigned to receive either 15 milligrams of saffron per day or a placebo. The trial lasted for 12 weeks, during which information regarding participants’ biochemical markers and heart health was recorded. Results demonstrated reductions in low-density lipoprotein cholesterol, triglycerides, and inflammation markers in the saffron group compared to the placebo group. Additionally, the saffron group showed an increase in high-density lipoprotein, cholesterol and heart protection. No adverse reactions or side effects were observed in the saffron group. Overall, the study suggests that saffron improves blood lipid levels, inflammation, and heart health in women with PCOS. However, due to the limited sample size, additional research is needed to explore other potential factors, such as different doses and durations of use, to determine the optimal use of saffron in PCOS treatment. In a double-blind, randomized controlled trial (Kazemi et al., 2021), researchers compared saffron with fluoxetine, a commonly used antidepressant and anti-obsessive-compulsive medication, in the treatment of mild to moderate obsessive-compulsive disorder (OCD). This study randomly assigned 60 patients with mild to moderate OCD to receive either a 15 mg daily saffron supplement or a 20 mg daily fluoxetine dosage. The trial lasted for eight weeks, during which information about participants’ obsessive symptoms and mental state was recorded. Both the saffron and fluoxetine groups showed significant clinical improvement, but there was no significant difference between the two groups. However, it is important to note that fewer adverse reactions occurred in the saffron group than in the fluoxetine group, suggesting that saffron may have a higher safety profile compared to fluoxetine. Consequently, this study suggests that saffron may be an alternative treatment for OCD and a better option for patients who are intolerant to or experience adverse reactions to fluoxetine. Although these results are encouraging, the limited sample size emphasizes the need for further studies on other potential factors, such as different doses and duration of use, to determine the optimal use of saffron in the treatment of OCD. Conclusions and Outlooks It is well-known that it is difficult to completely resolve malignant tumors. Therefore, it is required to conduct scheduled, reasonable, and standardized treatment according to the biological characteristics of tumors, patients’ conditions, disease stages, and development trends. For the treatment of malignant tumors, it is necessary to take account of the effectiveness and safety of treatment and the survival time of patients. Furthermore, the treatment costs, subjective feelings, and quality of life of patients shall also be considered during treatment. Crocin, as a type carotenoid with a great medicinal value, has wide anti-tumor efficacy and inhibitory effects in a variety of malignant tumors, such as gastric cancer, liver cancer, cervical, breast cancer and colorectal cancer. Crocin exerts its anti-tumor effect mainly by promoting apoptosis, inhibiting malignant proliferation, and interfering cell cycle of tumor cells. Although crocin is well tolerated and has high safety (Javandoost et al., 2017; Kazemi et al., 2021; Rahimi, Shams & Aslani, 2022), the research on crocin only focuses on in vitro experiments and rodent models, and further studies are needed to determine the optimal dose and verify its safety for human use. Favorable anti-tumor effects have been observed in various tumors, but the mechanism has not been clearly uncovered. The bioavailability of carotenoid components is not high due to complex factors affecting their absorption, decomposition, transport and storage. Crocin has low stability and poor absorption, which affects its bioavailability (Puglia et al., 2019). Research has shown that it is not well-absorbed after oral administration and quickly hydrolyzes to crocetin in the intestine (Xi et al., 2007). However, under in vitro simulated gastrointestinal digestion conditions, the bioavailability of crocin can reach up to 50% (Kyriakoudi et al., 2013), suggesting that its bioavailability can be improved under certain conditions. Nanocarriers can overcome the restriction of drug action by body barriers (such as the blood–brain barrier and blood–eye barrier) and can reduce drug doses, improve drug availability and reduce side effects after modification by targeted groups. Moreover, the extraction rate of crocin is low and the cost is high. Therefore, it is necessary to develop an efficient extraction process to further expand its application in the fields of clinical medicine, food and drug. As a natural compound, saffron has shown promising anticancer effects; however, its underlying mechanism and efficacy require further exploration. Future research directions may include the following aspects: Mechanism of action: Investigation into the specific mechanisms of saffron in tumour therapy by elucidating its regulatory role in apoptosis, proliferation, invasion, metastasis, glucolipid metabolism, and other cellular processes. Rational drug use: Investigation into the safety, toxicity, and side effects of saffron, as well as its indications for different types of cancer, to develop rational drug-use plans that improve clinical outcomes. Development of novel saffron derivatives: Use of molecular modification, synthetic biology, and other technologies to design and synthesize novel saffron derivatives with enhanced anticancer activity and pharmacological properties while reducing adverse reactions. Drug combination: Study the combined application of saffron with other drugs to explore its synergistic effect, advantages, and expand its application range in tumour therapy. Basic research: Conduct in-depth exploration of the interactions between saffron and tumor cells, immune system, and other related biological systems at a basic research level to improve our knowledge and understanding of the anticancer mechanisms of saffron. Given the increasing demand for effective tumor therapies and the constant progress in science and technology, the research and development of saffron in the field of anticancer will remain a hot spot and an essential direction for future study. In summary, crocin has a great potential in defeating tumors. Especially, the processed and modified nanoliposome delivery for crocin is expected to become a novel anti-tumor drug. It is believed that the anti-tumor pharmacological mechanism of crocin will be further explored and verified in the future. Abbreviations Bcl-2 B cell lymphoma-2 Bax Bcl-2-associated X CDK Cyclin-dependent kinase Cyt-c Cytochrome C JAK Janus kinase STAT3 Signal transducer and activator of transcription 3 ERK extracellular signal-regulated kinase SHP-1 Src homology region 2 domain-containing phosphatase 1 CXCR Chemokine CXC motif receptor VEGF Vascular endothelial growth factor IL Interleukin ROS Reactive oxygen species PTC Papillary thyroid cancer PTPN Protein tyrosine phosphatase nonreceptor LDH Lactate dehydrogenase FOXO3a Forkhead box O3 PTEN Phosphatase and tensin AKT Protein kinase B TPM Tropomyosin NF- κB Nuclear factor kappa-B Nrf2 Nuclear transcription factor E2 related factor 2 EMT Epithelial-mesenchymal transition MMP Matrix metalloproteinase MNNG 1-methyl-3-nitroso-1-nitroguanidine KLF5 Krüppel like factor 5 HIF-1 α Hypoxia inducible factor-1 α MNPs Magnetic nanoparticles COX-2 Cyclooxygenase-2 MRP Multiple resistance-associated proteins TNF- α Tumor necrosis factor- α CD Cluster of differentiation AMPK Adenosine 5′-monophosphate (AMP)-activated protein kinase mTOR Mammalian target of rapamycin NMU N-methyl-N-nitrosourea OCD Obsessive-compulsive disorder PCOS Polycystic ovary syndrome CETP Cholesterol ester transfer protein CIPN Chemotherapy-induced peripheral neuropathy Additional Information and Declarations Competing Interests Author Contributions Data Availability The authors declare there are no competing interests. Xingxun Bao conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft. Jinhua Hu conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft. Yan Zhao analyzed the data, prepared figures and/or tables, and approved the final draft. Ruixue Jia conceived and designed the experiments, analyzed the data, prepared figures and/or tables, and approved the final draft. Hairong Zhang performed the experiments, analyzed the data, authored or reviewed drafts of the article, and approved the final draft. Lei Xia performed the experiments, analyzed the data, authored or reviewed drafts of the article, and approved the final draft. The following information was supplied regarding data availability: This is a literature review and did not use raw data. ==== Refs References Abdu et al. (2022) Abdu S Juaid N Amin A Moulay M Miled N 2022 Therapeutic effects of crocin alone or in combination with sorafenib against hepatocellular carcinoma: in vivo & in vitro insights Antioxidants 11 9 1645 10.3390/antiox11091645 36139719 Agarwal et al. (2018) Agarwal S Milazzo G Rajapakshe K Bernardi R Chen Z Barbieri E Koster J Perini G Coarfa C Shohet JM 2018 MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma Oncotarget 9 20323 20338 10.18632/oncotarget.24859 29755654 Agupitan et al. (2020) Agupitan AD Neeson P Williams S Howitt J Haupt S Haupt Y 2020 P53: a guardian of immunity becomes its saboteur through mutation International Journal of Molecular Sciences 21 10 3452 10.3390/ijms21103452 32414156 Algandaby (2018) Algandaby MM 2018 Antifibrotic effects of crocin on thioacetamide-induced liver fibrosis in mice Saudi Journal of Biological Sciences 25 747 754 10.1016/j.sjbs.2016.10.007 29740240 Amelio, Melino & Knight (2011) Amelio I Melino G Knight RA 2011 Cell death pathology: cross-talk with autophagy and its clinical implications Biochemical and Biophysical Research Communications 414 277 281 10.1016/j.bbrc.2011.09.080 21963447 Amerizadeh et al. (2018) Amerizadeh F Rezaei N Rahmani F Hassanian SM Moradi-Marjaneh R Fiuji H Boroumand N Nosrati-Tirkani A Ghayour-Mobarhan M Ferns GA Khazaei M Avan A 2018 Crocin synergistically enhances the antiproliferative activity of 5-flurouracil through Wnt/PI3K pathway in a mouse model of colitis-associated colorectal cancer Journal of Cellular Biochemistry 119 10250 10261 10.1002/jcb.27367 30129057 Amin et al. (2014) Amin B Abnous K Motamedshariaty V Hosseinzadeh H 2014 Attenuation of oxidative stress, inflammation and apoptosis by ethanolic and aqueous extracts of Crocus sativus L. stigma after chronic constriction injury of rats Anais da Academia Brasileira de Ciencias 86 1821 1832 10.1590/0001-3765201420140067 25590719 Amin et al. (2015) Amin A Bajbouj K Koch A Gandesiri M Schneider-Stock R 2015 Defective autophagosome formation in p53-null colorectal cancer reinforces crocin-induced apoptosis International Journal of Molecular Sciences 16 1544 1561 10.3390/ijms16011544 25584615 Amin et al. (2016) Amin A Hamza AA Daoud S Khazanehdari K Hrout AA Baig B Chaiboonchoe A Adrian TE Zaki N Salehi-Ashtiani K 2016 Saffron-based crocin prevents early lesions of liver cancer: in vivo, in vitro and network analyses Recent Patents on Anti-Cancer Drug Discovery 11 121 133 10.2174/1574892810666151102110248 26522014 Arzi et al. (2018) Arzi L Farahi A Jafarzadeh N Riazi G Sadeghizadeh M Hoshyar R 2018 Inhibitory effect of crocin on metastasis of triple-negative breast cancer by interfering with Wnt/ β-catenin pathway in murine model DNA and Cell Biology 37 1068 1075 10.1089/dna.2018.4351 30351203 Ashrafi et al. (2015) Ashrafi M Bathaie SZ Abroun S Azizian M 2015 Effect of crocin on cell cycle regulators in N-Nitroso-N-methylurea-induced breast cancer in rats DNA and Cell Biology 34 684 691 10.1089/dna.2015.2951 26394119 Aung et al. (2007) Aung HH Wang CZ Ni M Fishbein A Mehendale SR Xie JT Shoyama CY Yuan CS 2007 Crocin from Crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells Experimental Oncology 29 175 180 18004240 Bakshi et al. (2017a) Bakshi HA Hakkim FL Sam S Javid F 2017a Role of dietary crocin in in vivo melanoma tumor remission Asian Pacific Journal of Cancer Prevention 18 841 846 10.22034/apjcp.2017.18.3.841 28441796 Bakshi et al. (2017b) Bakshi HA Hakkim FL Sam S Javid F Rashan L 2017b Dietary crocin reverses melanoma metastasis The Journal of Biomedical Research 32 39 50 10.7555/jbr.31.20160120 29219852 Bakshi et al. (2022) Bakshi HA Quinn GA Nasef MM Mishra V Aljabali AAA El-Tanani M Á Serrano-Aroca Webba Da Silva M McCarron PA Tambuwala MM 2022 Crocin inhibits angiogenesis and metastasis in colon cancer via TNF- α/NF-kB/VEGF pathways Cells 11 9 1502 10.3390/cells11091502 35563808 Bakshi et al. (2020) Bakshi HA Zoubi MSA Hakkim FL Aljabali AAA Rabi FA Hafiz AA Al-Batanyeh KM Al-Trad B Ansari P Nasef MM Charbe NB Satija S Mehta M Mishra V Gupta G Abobaker S Negi P Azzouz IM Dardouri AAK Dureja H Prasher P Chellappan DK Dua K Webba da Silva M El Tanani M McCarron PA Tambuwala MM 2020 Dietary crocin is protective in pancreatic cancer while reducing radiation-induced hepatic oxidative damage Nutrients 12 6 1901 10.3390/nu12061901 32604971 Bi et al. (2021) Bi X Jiang Z Luan Z Qiu D 2021 Crocin exerts anti-proliferative and apoptotic effects on cutaneous squamous cell carcinoma via miR-320a/ATG2B Bioengineered 12 4569 4580 10.1080/21655979.2021.1955175 34320900 Binarová & Tuszynski (2019) Binarová P Tuszynski J 2019 Tubulin: structure, functions and roles in disease Cells 8 10 1294 10.3390/cells8101294 31652491 Bozorgi et al. (2021) Bozorgi H Ghahremanfard F Motaghi E Zamaemifard M Zamani M Izadi A 2021 Effectiveness of crocin of saffron (Crocus sativus L.) against chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled clinical trial Journal of Ethnopharmacology 281 114511 10.1016/j.jep.2021.114511 34390797 Brabletz et al. (2021) Brabletz S Schuhwerk H Brabletz T Stemmler MP 2021 Dynamic EMT: a multi-tool for tumor progression The EMBO Journal 40 e108647 10.15252/embj.2021108647 34459003 Brewczyński et al. (2021) Brewczyński A Jabłońska B Kentnowski M Mrowiec S Składowski K Rutkowski T 2021 The association between carotenoids and head and neck cancer risk Nutrients 14 1 88 10.3390/nu14010088 35010963 Carmeliet (2005) Carmeliet P 2005 VEGF as a key mediator of angiogenesis in cancer Oncology 69 Suppl 3 4 10 10.1159/000088478 16301830 Chen et al. (2019) Chen SS Gu Y Lu F Qian DP Dong TT Ding ZH Zhao S Yu ZH 2019 Antiangiogenic effect of crocin on breast cancer cell MDA-MB-231 Journal of Thoracic Disease 11 4464 4473 10.21037/jtd.2019.11.18 31903234 Chen et al. (2016) Chen SS Zhao S Gu Y Jiang EZ Zhu JU Yu ZH 2016 Experimental study on antiangiogenic effect of crocin on breast cancer Chinese Clinical Oncology 21 397 403 Deng et al. (2019) Deng L Li J Lu S Su Y 2019 Crocin inhibits proliferation and induces apoptosis through suppressing MYCN expression in retinoblastoma Journal of Biochemical and Molecular Toxicology 33 e22292 10.1002/jbt.22292 30672053 Díaz-Coránguez, Liu & Antonetti (2019) Díaz-Coránguez M Liu X Antonetti DA 2019 Tight junctions in cell proliferation International Journal of Molecular Sciences 20 23 5972 10.3390/ijms20235972 31783547 El-Kharrag et al. (2017) El-Kharrag R Amin A Hisaindee S Greish Y Karam SM 2017 Development of a therapeutic model of precancerous liver using crocin-coated magnetite nanoparticles International Journal of Oncology 50 212 222 10.3892/ijo.2016.3769 27878253 Elsherbiny et al. (2020) Elsherbiny NM Eisa NH El-Sherbiny M Said E 2020 Chemo-preventive effect of crocin against experimentally-induced hepatocarcinogenesis via regulation of apoptotic and Nrf2 signaling pathways Environmental Toxicology and Pharmacology 80 103494 10.1016/j.etap.2020.103494 32942000 Farahi et al. (2021) Farahi A Abedini MR Javdani H Arzi L Chamani E Farhoudi R Talebloo N Hoshyar R 2021 Crocin and Metformin suppress metastatic breast cancer progression via VEGF and MMP9 downregulations: in vitro and in vivo studies Molecular and Cellular Biochemistry 476 3341 3351 10.1007/s11010-020-04043-8 33929675 Feidantsis et al. (2018) Feidantsis K Mellidis K Galatou E Sinakos Z Lazou A 2018 Treatment with crocin improves cardiac dysfunction by normalizing autophagy and inhibiting apoptosis in STZ-induced diabetic cardiomyopathy Nutrition, Metabolism and Cardiovascular Diseases 28 952 961 10.1016/j.numecd.2018.06.005 Finley & Gao (2017) Finley JW Gao S 2017 A Perspective on Crocus sativus L. (Saffron) constituent crocin: a potent water-soluble antioxidant and potential therapy for alzheimer’s disease Journal of Agricultural and Food Chemistry 65 1005 1020 10.1021/acs.jafc.6b04398 28098452 Fitzmaurice et al. (2017) Fitzmaurice C Allen C Barber RM Barregard L Bhutta ZA Brenner H Dicker DJ Chimed-Orchir O Dandona R Dandona L Fleming T Forouzanfar MH Hancock J Hay RJ Hunter-Merrill R Huynh C Hosgood HD Johnson CO Jonas JB Khubchandani J Kumar GA Kutz M Lan Q Larson HJ Liang X Lim SS Lopez AD MacIntyre MF Marczak L Marquez N Mokdad AH Pinho C Pourmalek F Salomon JA Sanabria JR Sandar L Sartorius B Schwartz SM Shackelford KA Shibuya K Stanaway J Steiner C Sun J Takahashi K Vollset SE Vos T Wagner JA Wang H Westerman R Zeeb H Zoeckler L Abd-Allah F Ahmed MB Alabed S Alam NK Aldhahri SF Alem G Alemayohu MA Ali R Al-Raddadi R Amare A Amoako Y Artaman A Asayesh H Atnafu N Awasthi A Saleem HB Barac A Bedi N Bensenor I Berhane A Bernabé E Betsu B Binagwaho A Boneya D Campos-Nonato I Castañeda Orjuela C Catalá-López F Chiang P Chibueze C Chitheer A Choi JY Cowie B Damtew S Neves Jdas Dey S Dharmaratne S Dhillon P Ding E Driscoll T Ekwueme D Endries AY Farvid M Farzadfar F Fernandes J Fischer F GH TT Gebru A Gopalani S Hailu A Horino M Horita N Husseini A Huybrechts I Inoue M Islami F Jakovljevic M James S Javanbakht M Jee SH Kasaeian A Kedir MS Khader YS Khang YH Kim D Leigh J Linn S Lunevicius R Razek HMAEl Malekzadeh R Malta DC Marcenes W Markos D Melaku YA Meles KG Mendoza W Mengiste DT Meretoja TJ Miller TR Mohammad KA Mohammadi A Mohammed S Moradi-Lakeh M Nagel G Nand D Nguyen QLe Nolte S Ogbo FA Oladimeji KE Oren E Pa M Park EK Pereira DM Plass D Qorbani M Radfar A Rafay A Rahman M Rana SM Søreide K Satpathy M Sawhney M Sepanlou SG Shaikh MA She J Shiue I Shore HR Shrime MG So S Soneji S Stathopoulou V Stroumpoulis K Sufiyan MB Sykes BL Tabarés-Seisdedos R Tadese F Tedla BA Tessema GA Thakur JS Tran BX Ukwaja KN Uzochukwu BSC Vlassov VV Weiderpass E Terefe MWubshet Yebyo HG Yimam HH Yonemoto N Younis MZ Yu C Zaidi Z Zaki MES Zenebe ZM Murray CJL Naghavi M 2017 Global regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncology 3 524 548 10.1001/jamaoncol.2016.5688 27918777 Ghaeni et al. (2014) Ghaeni FA Amin B Hariri AT Meybodi NT Hosseinzadeh H 2014 Antilithiatic effects of crocin on ethylene glycol-induced lithiasis in rats Urolithiasis 42 549 558 10.1007/s00240-014-0711-y 25173352 Guan et al. (2020) Guan X Guan X Dong C Jiao Z 2020 Rho GTPases and related signaling complexes in cell migration and invasion Experimental Cell Research 388 111824 10.1016/j.yexcr.2020.111824 31926148 Guo et al. (2021) Guo ZL Li MX Li XL Wang P Wang WG Du WZ Yang ZQ Chen SF Wu D Tian XY 2021 Crocetin: a systematic review Frontiers in Pharmacology 12 745683 10.3389/fphar.2021.745683 35095483 Hashemi, Bathaie & Mohagheghi (2020) Hashemi SA Bathaie SZ Mohagheghi MA 2020 Crocetin and crocin decreased cholesterol and triglyceride content of both breast cancer tumors and cell lines Avicenna Journal of Phytomedicine 10 384 397 32850295 Hashemzaei et al. (2020) Hashemzaei M Mamoulakis C Tsarouhas K Georgiadis G Lazopoulos G Tsatsakis A Shojaei Asrami E Rezaee R 2020 Crocin: a fighter against inflammation and pain Food and Chemical Toxicology 143 111521 10.1016/j.fct.2020.111521 32640351 He et al. (2010) He B Tian J Li CH Liu Y 2010 Content variation of 4 mainly components in Fructus Gardeniae of different maturity anddifferent parts Chinese Journal of Pharmaceutical Analysis 30 801 805 10.16155/j.0254-1793.2010.05.023 Hire et al. (2017) Hire RR Srivastava S Davis MB Kumar Konreddy A Panda D 2017 Antiproliferative activity of crocin involves targeting of microtubules in breast cancer cells Scientific Reports 7 44984 10.1038/srep44984 28337976 Hoshyar, Bathaie & Sadeghizadeh (2013) Hoshyar R Bathaie SZ Sadeghizadeh M 2013 Crocin triggers the apoptosis through increasing the Bax/Bcl-2 ratio and caspase activation in human gastric adenocarcinoma, AGS, cells DNA and Cell Biology 32 50 57 10.1089/dna.2012.1866 23347444 Hoshyar et al. (2016) Hoshyar R Khayati GR Poorgholami M Kaykhaii M 2016 A novel green one-step synthesis of gold nanoparticles using crocin and their anti-cancer activities Journal of Photochemistry and Photobiology B 159 237 242 10.1016/j.jphotobiol.2016.03.056 Hoshyar & Mollaei (2017) Hoshyar R Mollaei H 2017 A comprehensive review on anticancer mechanisms of the main carotenoid of saffron, crocin Journal of Pharmacy and Pharmacology 69 1419 1427 10.1111/jphp.12776 28675431 Huang, Song & Xu (2020) Huang B Song BL Xu C 2020 Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities Nature Metabolism 2 132 141 10.1038/s42255-020-0174-0 Hussain et al. (2021) Hussain MA Abogresha NM AbdelKader G Hassan R Abdelaziz EZ Greish SM 2021 Antioxidant and anti-inflammatory effects of crocin ameliorate doxorubicin-induced nephrotoxicity in rats Oxidative Medicine and Cellular Longevity 2021 8841726 10.1155/2021/8841726 33628387 Jahromi et al. (2021) Jahromi AS Kargar M Kafilzadeh F Jamalidoust M Moradzadeh M 2021 Crocin promotes apoptosis in human EBV-transformed B-lymphocyte via intrinsic pathway Mediterranean Journal of Hematology and Infectious Diseases 13 e2021049 10.4084/mjhid.2021.049 34276918 Jarrett et al. (2018) Jarrett AM Lima E Hormuth 2nd DA McKenna MT Feng X Ekrut DA Resende ACM Brock A Yankeelov TE 2018 Mathematical models of tumor cell proliferation: a review of the literature Expert Review of Anticancer Therapy 18 1271 1286 10.1080/14737140.2018.1527689 30252552 Javandoost et al. (2017) Javandoost A Afshari A Nikbakht-Jam I Khademi M Eslami S Nosrati M Foroutan-Tanha M Sahebkar A Tavalaie S Ghayour-Mobarhan M Ferns G Hadizadeh F Tabassi A Mohajeri A 2017 Effect of crocin, a carotenoid from saffron, on plasma cholesteryl ester transfer protein and lipid profile in subjects with metabolic syndrome: a double blind randomized clinical trial ARYA Atherosclerosis 13 245 252 29371871 Jiang et al. (2018) Jiang Z Gu M Liu J Li H Peng J Zhang Y 2018 Anticancer activity of crocin against cervical carcinoma (HeLa cells): bioassessment and toxicity evaluation of crocin in male albino rats Journal of Photochemistry and Photobiology B 180 118 124 10.1016/j.jphotobiol.2018.01.013 Johnson, O’Keefe & Grandis (2018) Johnson DE O’Keefe RA Grandis JR 2018 Targeting the IL-6/JAK/STAT3 signalling axis in cancer Nature Reviews Clinical Oncology 15 234 248 10.1038/nrclinonc.2018.8 Joseph et al. (2020) Joseph C Alsaleem M Orah N Narasimha PL Miligy IM Kurozumi S Ellis IO Mongan NP Green AR Rakha EA 2020 Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival Breast Cancer Research and Treatment 182 267 282 10.1007/s10549-020-05670-x 32445177 Kawabata et al. (2012) Kawabata K Tung NH Shoyama Y Sugie S Mori T Tanaka T 2012 Dietary crocin inhibits colitis and colitis-associated colorectal carcinogenesis in male ICR mice Evidence-Based Complementary and Alternative Medicine 2012 820415 10.1155/2012/820415 23326291 Kazemi et al. (2021) Kazemi F Vosough I Sepahi S Mohajeri SA 2021 Effect of crocin versus fluoxetine in treatment of mild to moderate obsessive-compulsive disorder: a double blind randomized clinical trial Human Psychopharmacology 36 e2780 10.1002/hup.2780 33599345 Khan et al. (2020) Khan I Joshi G Sarkar B Nakhate KT Ajazuddin Mantha AK Kumar R Kaul A Chaturvedi S Mishra AK Gupta U 2020 Doxorubicin and crocin co-delivery by polymeric nanoparticles for enhanced anticancer potential in vitro and in vivo ACS Applied Bio Materials 3 7789 7799 10.1021/acsabm.0c00974 Khavari et al. (2015) Khavari A Bolhassani A Alizadeh F Bathaie SZ Balaram P Agi E Vahabpour R 2015 Chemo-immunotherapy using saffron and its ingredients followed by E7-NT (gp96) DNA vaccine generates different anti-tumor effects against tumors expressing the E7 protein of human papillomavirus Archives of Virology 160 499 508 10.1007/s00705-014-2250-9 25395243 Kim & Park (2018) Kim B Park B 2018 Saffron carotenoids inhibit STAT3 activation and promote apoptotic progression in IL-6-stimulated liver cancer cells Oncology Reports 39 1883 1891 10.3892/or.2018.6232 29393468 Klionsky, Cuervo & Seglen (2007) Klionsky DJ Cuervo AM Seglen PO 2007 Methods for monitoring autophagy from yeast to human Autophagy 3 181 206 10.4161/auto.3678 17224625 Kulsoom et al. (2018) Kulsoom B Shamsi TS Afsar NA Memon Z Ahmed N Hasnain SN 2018 Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy? Cancer Management and Research 10 403 416 10.2147/cmar.S154608 29535553 Kyriakoudi et al. (2013) Kyriakoudi A Tsimidou MZ O’Callaghan YC Galvin K O’Brien NM 2013 Changes in total and individual crocetin esters upon in vitro gastrointestinal digestion of saffron aqueous extracts Journal of Agricultural and Food Chemistry 61 5318 5327 10.1021/jf400540y 23654200 Li (2020) Li J 2020 Saffron Henan Agriculture 7 65 10.15904/j.cnki.hnny.2022.07.032 Li et al. (2021a) Li W He P Huang Y Li YF Lu J Li M Kurihara H Luo Z Meng T Onishi M Ma C Jiang L Hu Y Gong Q Zhu D Xu Y Liu R Liu L Yi C Zhu Y Ma N Okamoto K Xie Z Liu J He RR Feng D 2021a Selective autophagy of intracellular organelles: recent research advances Theranostics 11 222 256 10.7150/thno.49860 33391472 Li et al. (2021b) Li P Ji BY Wei J Du XJ Huang F 2021b Synergistic inhibitory effects of crocin and cisplatin on human cervical cancer Hela cells Anti-tumor Pharmacy 11 701 706 Li, Lee & Wu (2004) Li CY Lee EJ Wu TS 2004 Antityrosinase principles and constituents of the petals of Crocus sativus Journal of Natural Products 67 437 440 10.1021/np0302854 15043425 Li et al. (2017) Li YJ Lei YH Yao N Wang CR Hu N Ye WC Zhang DM Chen ZS 2017 Autophagy and multidrug resistance in cancer Chinese Journal of Cancer 36 52 10.1186/s40880-017-0219-2 28646911 Li et al. (2018) Li L Zhang H Jin S Liu C 2018 Effects of crocin on inflammatory activities in human fibroblast-like synoviocytes and collagen-induced arthritis in mice Immunologic Research 66 406 413 10.1007/s12026-018-8999-2 29777367 Liao et al. (2022) Liao BL Zhou Y Xu QH Tian TN Chang N Zhang HJ 2022 Crocetin affects the proliferation, invasion and apoptosis of gastric cancer cell line MGC-803 byregulating tubulin Saffin affects the proliferation, invasion and apoptosis of gastric cancer cellline MGC-803 by regulating tubulin Modern Digestion & Intervention 27 311 315 Liu (2016) Liu BL 2016 Effect of crocin on the apoptosis of HPAC cells in human pancreatic carcinoma Modern Medicine Journal of China 18 6 9 Liu et al. (2016) Liu Z Ding Y Ye N Wild C Chen H Zhou J 2016 Direct activation of bax protein for cancer therapy Medicinal Research Reviews 36 313 341 10.1002/med.21379 26395559 Liu et al. (2021) Liu D Liu FY Huang Y Duan YH Deng AH 2021 Research progress of crocin Farm Products Processing 74 76+82 10.16693/j.cnki.1671-9646(X).2021.11.020 Liu et al. (2018) Liu W Sun Y Cheng Z Guo Y Liu P Wen Y 2018 Crocin exerts anti-inflammatory and anti-arthritic effects on type II collagen-induced arthritis in rats Pharmaceutical Biology 56 209 216 10.1080/13880209.2018.1448874 29540097 Luo et al. (2017) Luo Y Cui S Tang F Shen C Qi Y Lu D Ma L Yang Y Li Y Chen R Ri-Li GE 2017 The combination of crocin with cisplatin suppresses growth of gastric carcinoma cell line BGC-823 and promotes cell apoptosis Pakistan Journal of Pharmaceutical Sciences 30 1629 1634 29084683 Luo et al. (2019) Luo L Fang K Dan X Gu M 2019 Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice Lipids in Health and Disease 18 11 10.1186/s12944-018-0955-6 30621686 Luo et al. (2021) Luo Y Yu P Zhao J Guo Q Fan B Diao Y Jin Y Wu J Zhang C 2021 Inhibitory effect of crocin against gastric carcinoma via regulating TPM4 gene OncoTargets and Therapy 14 111 122 10.2147/ott.S254167 33442270 Mahdizadeh et al. (2016) Mahdizadeh S Karimi G Behravan J Arabzadeh S Lage H Kalalinia F 2016 Crocin suppresses multidrug resistance in MRP overexpressing ovarian cancer cell line Daru 24 17 10.1186/s40199-016-0155-8 27342070 Matthews, Bertoli & De Bruin (2022) Matthews HK Bertoli C De Bruin RAM 2022 Cell cycle control in cancer Nature Reviews Molecular Cell Biology 23 74 88 10.1038/s41580-021-00404-3 34508254 Merino Salvador et al. (2017) Merino Salvador M Gómez de Cedrón M Moreno Rubio J Falagán Martínez S Sánchez Martínez R Casado E Ramírez de Molina A Sereno M 2017 Lipid metabolism and lung cancer Critical Reviews in Oncology/Hematology 112 31 40 10.1016/j.critrevonc.2017.02.001 28325263 Milani et al. (2017) Milani A Basirnejad M Shahbazi S Bolhassani A 2017 Carotenoids: biochemistry, pharmacology and treatment British Journal of Pharmacology 174 1290 1324 10.1111/bph.13625 27638711 Mirzaee et al. (2019) Mirzaee S Ehsan Bayatpoor M Shahyad S Taghi Mohammadi M Bahari Z 2019 The protective effects of Crocin on testopathy in fat-fed and streptozotocin-treated diabetic rats: an experimental study International Journal of Reproductive BioMedicine 17 89 98 10.18502/ijrm.v17i2.3986 31435592 Mohammadi et al. (2018) Mohammadi E Mehri S Bostan HBadie Hosseinzadeh H 2018 Protective effect of crocin against d-galactose-induced aging in mice Avicenna Journal of Phytomedicine 8 14 23 29387570 Mollaei et al. (2017) Mollaei H Safaralizadeh R Babaei E Abedini MR Hoshyar R 2017 The anti-proliferative and apoptotic effects of crocin on chemosensitive and chemoresistant cervical cancer cells Biomedicine & Pharmacotherapy 94 307 316 10.1016/j.biopha.2017.07.052 28763753 Moloney & Cotter (2018) Moloney JN Cotter TG 2018 ROS signalling in the biology of cancer Seminars in Cell & Developmental Biology 80 50 64 10.1016/j.semcdb.2017.05.023 28587975 Mousavi et al. (2011) Mousavi SH Moallem SA Mehri S Shahsavand S Nassirli H Malaekeh-Nikouei B 2011 Improvement of cytotoxic and apoptogenic properties of crocin in cancer cell lines by its nanoliposomal form Pharmaceutical Biology 49 1039 1045 10.3109/13880209.2011.563315 21936628 Mozaffari et al. (2019) Mozaffari S Ramezany Yasuj S Motaghinejad M Motevalian M Kheiri R 2019 Crocin acting as a neuroprotective agent against methamphetamine-induced neurodegeneration via CREB-BDNF signaling pathway Iranian Journal of Pharmaceutical Research 18 745 758 10.22037/ijpr.2019.2393 31531058 Nasimian et al. (2020) Nasimian A Farzaneh P Tamanoi F Bathaie SZ 2020 Cytosolic and mitochondrial ROS production resulted in apoptosis induction in breast cancer cells treated with Crocin: The role of FOXO3a, PTEN and AKT signaling Biochemical Pharmacology 177 113999 10.1016/j.bcp.2020.113999 32353423 Pachikian et al. (2021) Pachikian BD Copine S Suchareau M Deldicque L 2021 Effects of saffron extract on sleep quality: a randomized double-blind controlled clinical trial Nutrients 13 5 1473 10.3390/nu13051473 33925432 Palassi et al. (2021) Palassi S Valizadeh H Allahyari S Zakeri-Milani P 2021 Preparation and in vitro characterization of enoxaparin nano-liposomes through different methods Advanced Pharmaceutical Bulletin 11 295 300 10.34172/apb.2021.042 33880351 Pistritto et al. (2016) Pistritto G Trisciuoglio D Ceci C Garufi A D’Orazi G 2016 Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies Aging 8 603 619 10.18632/aging.100934 27019364 Puglia et al. (2019) Puglia C Santonocito D Musumeci T Cardile V Graziano ACE Salerno L Raciti G Crascì L Panico AM Puglisi G 2019 Nanotechnological approach to increase the antioxidant and cytotoxic efficacy of crocin and crocetin Planta Medica 85 258 265 10.1055/a-0732-5757 30206907 Rahaiee et al. (2017) Rahaiee S Hashemi M Shojaosadati SA Moini S Razavi SH 2017 Nanoparticles based on crocin loaded chitosan-alginate biopolymers: antioxidant activities, bioavailability and anticancer properties International Journal of Biological Macromolecules 99 401 408 10.1016/j.ijbiomac.2017.02.095 28254570 Rahimi, Shams & Aslani (2022) Rahimi G Shams S Aslani MR 2022 Effects of crocin supplementation on inflammatory markers, lipid profiles, insulin and cardioprotective indices in women with PCOS: A randomized, double-blind, placebo-controlled trial Phytotherapy Research 36 2605 2615 10.1002/ptr.7474 35470916 Rahmani et al. (2019) Rahmani J Manzari N Thompson J Clark CCT Villanueva G Varkaneh HK Mirmiran P 2019 The effect of saffron on weight and lipid profile: a systematic review, meta-analysis, and dose–response of randomized clinical trials Phytotherapy Research 33 2244 2255 10.1002/ptr.6420 31264281 Randhawa & Alghamdi (2011) Randhawa MA Alghamdi MS 2011 Anticancer activity of Nigella sativa (black seed)—a review The American Journal of Chinese Medicine 39 1075 1091 10.1142/s0192415x1100941x 22083982 Rastgoo et al. (2013) Rastgoo M Hosseinzadeh H Alavizadeh H Abbasi A Ayati Z Jaafari MR 2013 Antitumor activity of PEGylated nanoliposomes containing crocin in mice bearing C26 colon carcinoma Planta Medica 79 447 451 10.1055/s-0032-1328363 23539350 Sajjadi & Bathaie (2017) Sajjadi M Bathaie Z 2017 Comparative study on the preventive effect of saffron carotenoids, crocin and crocetin, in NMU-induced breast cancer in rats Cell Journal 19 94 101 28367420 Salek et al. (2021) Salek R Dehghani M Mohajeri SA Talaei A Fanipakdel A Javadinia SA 2021 Amelioration of anxiety, depression, and chemotherapy related toxicity after crocin administration during chemotherapy of breast cancer: a double blind, randomized clinical trial Phytotherapy Research 35 5143 5153 10.1002/ptr.7180 34164855 Schunk et al. (2021) Schunk SJ Floege J Fliser D Speer T 2021 WNT- β-catenin signalling—a versatile player in kidney injury and repair Nature Reviews Nephrology 17 172 184 10.1038/s41581-020-00343-w 32989282 Sepahi et al. (2018) Sepahi S Mohajeri SA Hosseini SM Khodaverdi E Shoeibi N Namdari M Tabassi SAS 2018 Effects of crocin on diabetic maculopathy: a placebo-controlled randomized clinical trial American Journal of Ophthalmology 190 89 98 10.1016/j.ajo.2018.03.007 29550187 Sheng et al. (2006) Sheng L Qian Z Zheng S Xi L 2006 Mechanism of hypolipidemic effect of crocin in rats: crocin inhibits pancreatic lipase European Journal of Pharmacology 543 116 122 10.1016/j.ejphar.2006.05.038 16828739 Shi et al. (2018) Shi L Zhao S Chen Q Wu Y Zhang J Li N 2018 Crocin inhibits RANKL-induced osteoclastogenesis by regulating JNK and NF- κB signaling pathways Molecular Medicine Reports 17 7947 7951 10.3892/mmr.2018.8835 29620194 Song et al. (2022) Song R Han S Gao H Jiang H Li X 2022 Crocin alleviates cognitive impairment associated with atherosclerosis via improving neuroinflammation in LDLR(-/-) mice fed a high-fat/cholesterol diet Phytotherapy Research 36 1284 1296 10.1002/ptr.7384 35084779 Srinivas et al. (2019) Srinivas US Tan BWQ Vellayappan BA Jeyasekharan AD 2019 ROS and the DNA damage response in cancer Redox Biology 25 101084 10.1016/j.redox.2018.101084 30612957 Sun et al. (2013) Sun Y Xu HJ Zhao YX Wang LZ Sun LR Wang Z Sun XF 2013 Crocin exhibits antitumor effects on human leukemia hl-60 cells in vitro and in vivo Evidence-Based Complementary and Alternative Medicine 2013 690164 10.1155/2013/690164 23573146 Sung et al. (2021) Sung H Ferlay J Siegel RL Laversanne M Soerjomataram I Jemal A Bray F 2021 Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA: A Cancer Journal for Clinicians 71 209 249 10.3322/caac.21660 33538338 Tang et al. (2022) Tang Y Yang H Yu J Li Z Xu Q Ding B Jia G 2022 Crocin induces ROS-mediated papillary thyroid cancer cell apoptosis by modulating the miR-34a-5p/PTPN4 axis in vitro Toxicology and Applied Pharmacology 437 115892 10.1016/j.taap.2022.115892 35085590 Teng et al. (2021) Teng S Hao J Bi H Li C Zhang Y Zhang Y Han W Wang D 2021 The protection of crocin against ulcerative colitis and colorectal cancer via suppression of NF- κB-mediated inflammation Frontiers in Pharmacology 12 639458 10.3389/fphar.2021.639458 33841156 Tian et al. (2017) Tian TD Yue LY Tian TL Fan YX Zhang XF Ma XH 2017 Relationship between tumor lnflammation microenvironment and lmmunity along withintervening strategy of Chinese medicine Journal of Traditional Chinese Medicine 58 209 213 10.13288/j.11-2166/r.2017.03.009 Torres et al. (2011) Torres MA Raju U Molkentine D Riesterer O Milas L Ang KK 2011 AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivo Investigational New Drugs 29 554 561 10.1007/s10637-010-9389-3 20119866 Vazifedan et al. (2017) Vazifedan V Mousavi SH Sargolzaei J Soleymanifard S Fani Pakdel A 2017 Study of crocin & radiotherapy-induced cytotoxicity and apoptosis in the head and neck cancer (HN-5) cell line Iranian Journal of Pharmaceutical Research 16 230 237 28496478 Wang, Ke & Shu (2020) Wang J Ke Y Shu T 2020 Crocin has pharmacological effects against the pathological behavior of colon cancer cells by interacting with the STAT3 signaling pathway Experimental and Therapeutic Medicine 19 1297 1303 10.3892/etm.2019.8329 32010302 Wang et al. (2020) Wang Z Ren J Jin N Liu X Li X 2020 Is crocin a potential anti-tumor candidate targeting microtubules? Computational insights from molecular docking and dynamics simulations Frontiers in Molecular Biosciences 7 586970 10.3389/fmolb.2020.586970 33251248 Wu & Hui (2020) Wu Z Hui J 2020 Crocin reverses 1-methyl-3-nitroso-1-nitroguanidine (MNNG)-induced malignant transformation in GES-1 cells through the Nrf2/Hippo signaling pathway Journal of Gastrointestinal Oncology 11 1242 1252 10.21037/jgo-20-406 33456997 Xi et al. (2007) Xi L Qian Z Xu G Zheng S Sun S Wen N Sheng L Shi Y Zhang Y 2007 Beneficial impact of crocetin, a carotenoid from saffron, on insulin sensitivity in fructose-fed rats Journal of Nutritional Biochemistry 18 64 72 10.1016/j.jnutbio.2006.03.010 16713230 Xia (2015) Xia D 2015 Ovarian cancer HO-8910 cell apoptosis induced by crocin in vitro Natural Product Communications 10 249 252 25920253 Xiao et al. (2020) Xiao Q Shu R Wu C Tong Y Xiong Z Zhou J Yu C Xie X Fu Z 2020 Crocin-I alleviates the depression-like behaviors probably via modulating microbiota-gut-brain axis in mice exposed to chronic restraint stress Journal of Affective Disorders 276 476 486 10.1016/j.jad.2020.07.041 32871679 Xu, Lai & Hua (2019) Xu X Lai Y Hua ZC 2019 Apoptosis and apoptotic body: disease message and therapeutic target potentials Bioscience Reports 39 1 BSR20180992 10.1042/bsr20180992 30530866 Xu & Luo (2019) Xu CG Luo XS 2019 Crocin combined with cisplatin inhibits proliferation and apoptosis of gastric cancer cells by inhibiting ERK signaling pathway Journal of Shanxi Medical University 50 922 927 10.13753/j.issn.1007-6611.2019.07.010 Xu et al. (2022) Xu Q Yu J Jia G Li Z Xiong H 2022 Crocin attenuates NF- κB-mediated inflammation and proliferation in breast cancer cells by down-regulating PRKCQ Cytokine 154 155888 10.1016/j.cyto.2022.155888 35447530 Xu et al. (2012) Xu HJ Zhang KP Zhong R Zhao YX Li XR Lu Y Song AQ Pang XY Sun LR 2012 Influence of crocin on proliferation in vitro and function of dendritic cells derived from bone marrow of children with acute leukemia Journal of Experimental Hematology 20 57 61 22391165 Yamazaki et al. (2021) Yamazaki T Bravo-San Pedro JM Galluzzi L Kroemer G Pietrocola F 2021 Autophagy in the cancer-immunity dialogue Advanced Drug Delivery Reviews 169 40 50 10.1016/j.addr.2020.12.003 33301821 Yang et al. (2014) Yang H Yu J Wang L Ding D Zhang L Chu C Chen Q Xu Z Zou Q Liu X 2014 miR-320a is an independent prognostic biomarker for invasive breast cancer Oncology Letters 8 1043 1050 10.3892/ol.2014.2298 25120655 Yarijani et al. (2017) Yarijani ZM Pourmotabbed A Pourmotabbed T Najafi H 2017 Crocin has anti-inflammatory and protective effects in ischemia-reperfusion induced renal injuries Iranian Journal of Basic Medical Sciences 20 753 759 10.22038/ijbms.2017.9005 28852439 Yarla, Madka & Rao (2022) Yarla N Madka V Rao C 2022 Targeting triglyceride metabolism for colorectal cancer prevention and therapy Current Drug Targets 23 628 635 10.2174/1389450122666210824150012 34431463 Yi et al. (2018) Yi M Li J Chen S Cai J Ban Y Peng Q Zhou Y Zeng Z Peng S Li X Xiong W Li G Xiang B 2018 Emerging role of lipid metabolism alterations in Cancer stem cells Journal of Experimental & Clinical Cancer Research 37 118 10.1186/s13046-018-0784-5 29907133 Yin & Xiong (2022) Yin Q Xiong H 2022 Chemotherapy-induced nephrotoxicity was improved by crocin in mouse model European Journal of Histochemistry 66 4 3541 10.4081/ejh.2022.3541 36190398 Yu et al. (2020) Yu H Lin L Zhang Z Zhang H Hu H 2020 Targeting NF- κB pathway for the therapy of diseases: mechanism and clinical study Signal Transduction and Targeted Therapy 5 209 10.1038/s41392-020-00312-6 32958760 Yu et al. (2021) Yu F Yu C Li F Zuo Y Wang Y Yao L Wu C Wang C Ye L 2021 Wnt/ β-catenin signaling in cancers and targeted therapies Signal Transduction and Targeted Therapy 6 307 10.1038/s41392-021-00701-5 34456337 Zarei Jaliani et al. (2013) Zarei Jaliani H Riazi GH Ghaffari SM Karima O Rahmani A 2013 The effect of the Crocus sativus L. Carotenoid, crocin, on the polymerization of microtubules, in vitro Iranian Journal of Basic Medical Sciences 16 101 107 23638298 Zeng et al. (2019) Zeng A Hua H Liu L Zhao J 2019 Betulinic acid induces apoptosis and inhibits metastasis of human colorectal cancer cells in vitro and in vivo Bioorganic & Medicinal Chemistry 27 2546 2552 10.1016/j.bmc.2019.03.033 30910472 Zeng et al. (2016) Zeng C Li H Fan Z Zhong L Guo Z Guo Y Xi Y 2016 Crocin-elicited autophagy rescues myocardial ischemia/reperfusion injury via paradoxical mechanisms The American Journal of Chinese Medicine 44 515 530 10.1142/s0192415x16500282 27109157 Zhang & Brekken (2022) Zhang Y Brekken RA 2022 Direct and indirect regulation of the tumor immune microenvironment by VEGF Journal of Leukocyte Biology 111 1269 1286 10.1002/jlb.5ru0222-082r 35466428 Zhang et al. (2022b) Zhang H Lin J Shen Y Pan J Wang C Cheng L 2022b Protective effect of crocin on immune checkpoint inhibitors-related myocarditis through inhibiting NLRP3 mediated pyroptosis in cardiomyocytes via NF- κB pathway Journal of Inflammation Research 15 1653 1666 10.2147/jir.S348464 35282269 Zhang et al. (2022a) Zhang F Liu P He Z Zhang L He X Liu F Qi J 2022a Crocin ameliorates atherosclerosis by promoting the reverse cholesterol transport and inhibiting the foam cell formation via regulating PPAR γ/LXR- α Cell Cycle 21 202 218 10.1080/15384101.2021.2015669 34978526 Zhang et al. (2020a) Zhang C Liu J Xu D Zhang T Hu W Feng Z 2020a Gain-of-function mutant p53 in cancer progression and therapy Journal of Molecular Cell Biology 12 674 687 10.1093/jmcb/mjaa040 32722796 Zhang et al. (2018) Zhang K Wang L Si S Sun Y Pei W Ming Y Sun L 2018 Crocin improves the proliferation and cytotoxic function of T cells in children with acute lymphoblastic leukemia Biomedicine & Pharmacotherapy 99 96 100 10.1016/j.biopha.2018.01.042 29329036 Zhang et al. (2020b) Zhang J Yang S Wang K Huang Y Yang N Yang Z Zheng Z Wang Y 2020b Crocin induces autophagic cell death and inhibits cell invasion of cervical cancer SiHa cells through activation of PI3K/AKT Annals of Translational Medicine 8 1180 10.21037/atm-20-5882 33241029 Zhang et al. (2021) Zhang Y Zhu M Mohan SKrishna Hao Z 2021 Crocin treatment promotes the oxidative stress and apoptosis in human thyroid cancer cells FTC-133 through the inhibition of STAT/JAK signaling pathway Journal of Biochemical and Molecular Toxicology 35 e22608 10.1002/jbt.22608 32886819 Zhong et al. (2022) Zhong K Qian C Lyu R Wang X Hu Z Yu J Ma J Ye Y 2022 Anti-epileptic effect of crocin on experimental temporal lobe epilepsy in mice Frontiers in Pharmacology 13 757729 10.3389/fphar.2022.757729 35431921 Zhou et al. (2019) Zhou Y Xu Q Shang J Lu L Chen G 2019 Crocin inhibits the migration, invasion, and epithelial-mesenchymal transition of gastric cancer cells via miR-320/KLF5/HIF-1 α signaling Journal of Cellular Physiology 234 17876 17885 10.1002/jcp.28418 30851060